Skip to main content
NCBI home page
Gut logoLink to Gut
. 2001 Feb;48(2):163–167. doi: 10.1136/gut.48.2.163

Protective effect of metronidazole on uncoupling mitochondrial oxidative phosphorylation induced by NSAID: a new mechanism

A Leite 1, A Sipahi 1, A Damiao 1, A Coelho 1, A Garcez 1, M Machado 1, C Buchpiguel 1, F Lopasso 1, M Lordello 1, C Agostinho 1, A Laudanna 1
PMCID: PMC1728200  PMID: 11156635

Abstract

BACKGROUND—The pathogenesis of non-steroidal anti-inflammatory drug (NSAID) enteropathy is complex. It involves uncoupling of mitochondrial oxidative phosphorylation which alters the intercellular junction and increases intestinal permeability with consequent intestinal damage. Metronidazole diminishes the inflammation induced by indomethacin but the mechanisms remain speculative. A direct effect on luminal bacteria has traditionally been thought to account for the protective effect of metronidazole. However, a protective effect of metronidazole on mitochondrial oxidative phosphorylation has never been tested.
AIMS—To assess the protective effect of metronidazole on mitochondrial uncoupling induced by indomethacin and also on the increased intestinal permeability and macroscopic damage.
MATERIAL AND METHODS—The protective effect of metronidazole was evaluated in rats given indomethacin; a macroscopic score was devised to quantify intestinal lesions, and intestinal permeability was measured by means of 51Cr-ethylenediaminetetraacetic acid. The protective effect of metronidazole against mitochondrial uncoupling induced by indomethacin was assessed using isolated coupled rat liver mitochondria obtained from rats pretreated with metronidazole or saline.
RESULTS—Metronidazole significantly reduced the macroscopic intestinal damage and increase in intestinal permeability induced by indomethacin; furthermore, at the mitochondrial level, it significantly reduced the increase in oxygen consumption in state 4 induced by indomethacin and caused less reduction of the respiratory control rate.
CONCLUSION—Our study confirmed the beneficial effects of metronidazole on intestinal damage and intestinal permeability, and demonstrated, for the first time, a direct protective effect of metronidazole on uncoupling of mitochondrial oxidative phosphorylation caused by NSAIDs.


Keywords: uncoupling agents; intestinal permeability; enteropathy; non-steroidal anti-inflammatory drugs; metronidazole; indomethacin; rats

Full Text

The Full Text of this article is available as a PDF (159.3 KB).

Figure 1  .

Figure 1  

Open in a new tab

Box and whisker plot showing median macroscopic score (horizontal line), 25th and 75th centiles (box), and range (whiskers) in the control (group 1, n=10), indomethacin (group 2, n=10), and indomethacin plus metronidazole (group 3, n=10) groups. Group 1 v group 2, p<0.0001; group 1 v group 3, NS; group 2 v group 3, p<0.001.

Figure 2  .

Figure 2  

Open in a new tab

Box and whisker plot showing median intestinal permeability (horizontal line), 25th and 75th centiles (box), and range (whiskers) in the control (group 1, n=17), indomethacin (group 2, n=16), and indomethacin plus metronidazole (group 3, n=17) groups. Values are percentage of 51Cr-EDTA excreted in five hour urine. Group 1 v group 2, p<0.05; group 1 v group 3, NS; group 2 v group 3, p<0.05.

Figure 3  .

Figure 3  

Open in a new tab

Regression analysis of the effects of metronidazole on oxygen consumption in the basal state (S4) (values are µmol of oxygen/mg of protein).

Figure 4  .

Figure 4  

Open in a new tab

Regression analysis of the effects of metronidazole on respiratory control rate (RCR). Relation between consumption of oxygen with ADP (S3) and after it has been consumed (S4).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aabakken L., Osnes M. 51Cr-ethylenediaminetetraacetic acid absorption test. Effects of naproxen, a non-steroidal, antiinflammatory drug. Scand J Gastroenterol. 1990 Sep;25(9):917–924. doi: 10.3109/00365529008997613. [DOI] [PubMed] [Google Scholar]
  2. Aabakken L., Osnes M. Non-steroidal anti-inflammatory drug-induced disease in the distal ileum and large bowel. Scand J Gastroenterol Suppl. 1989;163:48–55. doi: 10.3109/00365528909091175. [DOI] [PubMed] [Google Scholar]
  3. Aicardi G., Solaini G. Effects of niridazole and 5-nitroimidazoles on heart mitochondrial respiration. Biochem Pharmacol. 1982 Nov 15;31(22):3703–3705. doi: 10.1016/0006-2952(82)90604-9. [DOI] [PubMed] [Google Scholar]
  4. Allison M. C., Howatson A. G., Torrance C. J., Lee F. D., Russell R. I. Gastrointestinal damage associated with the use of nonsteroidal antiinflammatory drugs. N Engl J Med. 1992 Sep 10;327(11):749–754. doi: 10.1056/NEJM199209103271101. [DOI] [PubMed] [Google Scholar]
  5. Banerjee A. K. Enteropathy induced by non-steroidal anti-inflammatory drugs. BMJ. 1989 Jun 10;298(6687):1539–1540. doi: 10.1136/bmj.298.6687.1539. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Bjarnason I., Fehilly B., Smethurst P., Menzies I. S., Levi A. J. Effects of nonsteroidal antiinflammatory drugs on permeability of the small intestine in humans. J Rheumatol Suppl. 1992 Nov;36:83–84. [PubMed] [Google Scholar]
  7. Bjarnason I., Fehilly B., Smethurst P., Menzies I. S., Levi A. J. Importance of local versus systemic effects of non-steroidal anti-inflammatory drugs in increasing small intestinal permeability in man. Gut. 1991 Mar;32(3):275–277. doi: 10.1136/gut.32.3.275. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Bjarnason I., Hayllar J., MacPherson A. J., Russell A. S. Side effects of nonsteroidal anti-inflammatory drugs on the small and large intestine in humans. Gastroenterology. 1993 Jun;104(6):1832–1847. doi: 10.1016/0016-5085(93)90667-2. [DOI] [PubMed] [Google Scholar]
  9. Bjarnason I., Hayllar J., Smethurst P., Price A., Gumpel M. J. Metronidazole reduces intestinal inflammation and blood loss in non-steroidal anti-inflammatory drug induced enteropathy. Gut. 1992 Sep;33(9):1204–1208. doi: 10.1136/gut.33.9.1204. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Bjarnason I., Macpherson A. The changing gastrointestinal side effect profile of non-steroidal anti-inflammatory drugs. A new approach for the prevention of a new problem. Scand J Gastroenterol Suppl. 1989;163:56–64. doi: 10.3109/00365528909091176. [DOI] [PubMed] [Google Scholar]
  11. Bjarnason I., Price A. B., Zanelli G., Smethurst P., Burke M., Gumpel J. M., Levi A. J. Clinicopathological features of nonsteroidal antiinflammatory drug-induced small intestinal strictures. Gastroenterology. 1988 Apr;94(4):1070–1074. doi: 10.1016/0016-5085(88)90568-9. [DOI] [PubMed] [Google Scholar]
  12. Bjarnason I., Smethurst P., Levi A. J., Peters T. J. Intestinal permeability to 51Cr-EDTA in rats with experimentally induced enteropathy. Gut. 1985 Jun;26(6):579–585. doi: 10.1136/gut.26.6.579. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Bjarnason I., Williams P., Smethurst P., Peters T. J., Levi A. J. Effect of non-steroidal anti-inflammatory drugs and prostaglandins on the permeability of the human small intestine. Gut. 1986 Nov;27(11):1292–1297. doi: 10.1136/gut.27.11.1292. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Bjarnason I., Zanelli G., Prouse P., Smethurst P., Smith T., Levi S., Gumpel M. J., Levi A. J. Blood and protein loss via small-intestinal inflammation induced by non-steroidal anti-inflammatory drugs. Lancet. 1987 Sep 26;2(8561):711–714. doi: 10.1016/s0140-6736(87)91075-0. [DOI] [PubMed] [Google Scholar]
  15. Bjarnason I., Zanelli G., Smith T., Prouse P., Williams P., Smethurst P., Delacey G., Gumpel M. J., Levi A. J. Nonsteroidal antiinflammatory drug-induced intestinal inflammation in humans. Gastroenterology. 1987 Sep;93(3):480–489. doi: 10.1016/0016-5085(87)90909-7. [DOI] [PubMed] [Google Scholar]
  16. Bjarnason I., Zanelli G., Smith T., Smethurst P., Price A. B., Gumpel M. J., Levi A. J. The pathogenesis and consequence of non steroidal anti-inflammatory drug induced small intestinal inflammation in man. Scand J Rheumatol Suppl. 1987;64:55–62. doi: 10.3109/03009748709096722. [DOI] [PubMed] [Google Scholar]
  17. Brodie D. A., Cook P. G., Bauer B. J., Dagle G. E. Indomethacin-induced intestinal lesions in the rat. Toxicol Appl Pharmacol. 1970 Nov;17(3):615–624. doi: 10.1016/0041-008x(70)90036-0. [DOI] [PubMed] [Google Scholar]
  18. Brune K., Dietzel K., Nürnberg B., Schneider H. T. Recent insight into the mechanism of gastrointestinal tract ulceration. Scand J Rheumatol Suppl. 1987;65:135–140. doi: 10.3109/03009748709102192. [DOI] [PubMed] [Google Scholar]
  19. CHANCE B., WILLIAMS G. R. A simple and rapid assay of oxidative phosphorylation. Nature. 1955 Jun 25;175(4469):1120–1121. doi: 10.1038/1751120a0. [DOI] [PubMed] [Google Scholar]
  20. Campbell K. L., De Beaux A. C. Non-steroidal anti-inflammatory drugs and appendicitis in patients aged over 50 years. Br J Surg. 1992 Sep;79(9):967–968. doi: 10.1002/bjs.1800790938. [DOI] [PubMed] [Google Scholar]
  21. Campbell K., Steele R. J. Non-steroidal anti-inflammatory drugs and complicated diverticular disease: a case-control study. Br J Surg. 1991 Feb;78(2):190–191. doi: 10.1002/bjs.1800780218. [DOI] [PubMed] [Google Scholar]
  22. Clements D., Williams G. T., Rhodes J. Colitis associated with ibuprofen. BMJ. 1990 Oct 27;301(6758):987–987. doi: 10.1136/bmj.301.6758.987-b. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Collins A. J., Davies J., Dixon S. A. Contrasting presentation and findings between patients with rheumatic complaints taking nonsteroidal anti-inflammatory drugs and a general population referred for endoscopy. Br J Rheumatol. 1986 Feb;25(1):50–53. doi: 10.1093/rheumatology/25.1.50. [DOI] [PubMed] [Google Scholar]
  24. Collins A. J., Du Toit J. A. Upper gastrointestinal findings and faecal occult blood in patients with rheumatic diseases taking nonsteroidal anti-inflammatory drugs. Br J Rheumatol. 1987 Aug;26(4):295–298. doi: 10.1093/rheumatology/26.4.295. [DOI] [PubMed] [Google Scholar]
  25. Coutrot S., Roland D., Barbier J., Van Der Marcq P., Alcalay M., Matuchansky C. Acute perforation of colonic diverticula associated with short-term indomethacin. Lancet. 1978 Nov 11;2(8098):1055–1056. doi: 10.1016/s0140-6736(78)92385-1. [DOI] [PubMed] [Google Scholar]
  26. Davies G. R., Wilkie M. E., Rampton D. S. Effects of metronidazole and misoprostol on indomethacin-induced changes in intestinal permeability. Dig Dis Sci. 1993 Mar;38(3):417–425. doi: 10.1007/BF01316493. [DOI] [PubMed] [Google Scholar]
  27. Davies N. M., Jamali F. Pharmacological protection of NSAID-induced intestinal permeability in the rat: effect of tempo and metronidazole as potential free radical scavengers. Hum Exp Toxicol. 1997 Jul;16(7):345–349. doi: 10.1177/096032719701600701. [DOI] [PubMed] [Google Scholar]
  28. Fang W. F., Broughton A., Jacobson E. D. Indomethacin-induced intestinal inflammation. Am J Dig Dis. 1977 Sep;22(9):749–760. doi: 10.1007/BF01694504. [DOI] [PubMed] [Google Scholar]
  29. Finkelstein J. A., Jamieson C. G. An association between anti-inflammatory medication and internal pelvic fistulas. Dis Colon Rectum. 1987 Mar;30(3):168–170. doi: 10.1007/BF02554329. [DOI] [PubMed] [Google Scholar]
  30. Geis G. S., Stead H., Wallemark C. B., Nicholson P. A. Prevalence of mucosal lesions in the stomach and duodenum due to chronic use of NSAID in patients with rheumatoid arthritis or osteoarthritis, and interim report on prevention by misoprostol of diclofenac associated lesions. J Rheumatol Suppl. 1991 Mar;28:11–14. [PubMed] [Google Scholar]
  31. Hall R. I., Petty A. H., Cobden I., Lendrum R. Enteritis and colitis associated with mefenamic acid. Br Med J (Clin Res Ed) 1983 Oct 22;287(6400):1182–1182. doi: 10.1136/bmj.287.6400.1182. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Hershfield N. B. Endoscopic demonstration of non-steroidal anti-inflammatory drug-induced small intestinal strictures. Gastrointest Endosc. 1992 May-Jun;38(3):388–390. doi: 10.1016/s0016-5107(92)70443-x. [DOI] [PubMed] [Google Scholar]
  33. Huber T., Ruchti C., Halter F. Nonsteroidal antiinflammatory drug-induced colonic strictures: a case report. Gastroenterology. 1991 Apr;100(4):1119–1122. doi: 10.1016/0016-5085(91)90291-r. [DOI] [PubMed] [Google Scholar]
  34. Jenkins R. T., Rooney P. J., Jones D. B., Bienenstock J., Goodacre R. L. Increased intestinal permeability in patients with rheumatoid arthritis: a side-effect of oral nonsteroidal anti-inflammatory drug therapy? Br J Rheumatol. 1987 Apr;26(2):103–107. doi: 10.1093/rheumatology/26.2.103. [DOI] [PubMed] [Google Scholar]
  35. Kaufmann H. J., Taubin H. L. Nonsteroidal anti-inflammatory drugs activate quiescent inflammatory bowel disease. Ann Intern Med. 1987 Oct;107(4):513–516. doi: 10.7326/0003-4819-107-4-513. [DOI] [PubMed] [Google Scholar]
  36. Kendall M. J., Nutter S., Hawkins C. F. Xylose test: effect of aspirin and indomethacin. Br Med J. 1971 Mar 6;1(5748):533–536. doi: 10.1136/bmj.1.5748.533. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Kent T. H., Cardelli R. M., Stamler F. W. Small intestinal ulcers and intestinal flora in rats given indomethacin. Am J Pathol. 1969 Feb;54(2):237–249. [PMC free article] [PubMed] [Google Scholar]
  38. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  39. Langman M. J. Epidemiologic evidence on the association between peptic ulceration and antiinflammatory drug use. Gastroenterology. 1989 Feb;96(2 Pt 2 Suppl):640–646. doi: 10.1016/s0016-5085(89)80060-5. [DOI] [PubMed] [Google Scholar]
  40. Madhok R., MacKenzie J. A., Lee F. D., Bruckner F. E., Terry T. R., Sturrock R. D. Small bowel ulceration in patients receiving non-steroidal anti-inflammatory drugs for rheumatoid arthritis. Q J Med. 1986 Jan;58(225):53–58. [PubMed] [Google Scholar]
  41. Mahmud T., Rafi S. S., Scott D. L., Wrigglesworth J. M., Bjarnason I. Nonsteroidal antiinflammatory drugs and uncoupling of mitochondrial oxidative phosphorylation. Arthritis Rheum. 1996 Dec;39(12):1998–2003. doi: 10.1002/art.1780391208. [DOI] [PubMed] [Google Scholar]
  42. Mahmud T., Somasundaram S., Sigthorsson G., Simpson R. J., Rafi S., Foster R., Tavares I. A., Roseth A., Hutt A. J., Jacob M. Enantiomers of flurbiprofen can distinguish key pathophysiological steps of NSAID enteropathy in the rat. Gut. 1998 Dec;43(6):775–782. doi: 10.1136/gut.43.6.775. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Malech H. L., Gallin J. I. Current concepts: immunology. Neutrophils in human diseases. N Engl J Med. 1987 Sep 10;317(11):687–694. doi: 10.1056/NEJM198709103171107. [DOI] [PubMed] [Google Scholar]
  44. Melarange R., Moore G., Blower P. R., Coates M. E., Ward F. W., Ronaasen V. A comparison of indomethacin with ibuprofen on gastrointestinal mucosal integrity in conventional and germ-free rats. Aliment Pharmacol Ther. 1992 Feb;6(1):67–77. doi: 10.1111/j.1365-2036.1992.tb00546.x. [DOI] [PubMed] [Google Scholar]
  45. Mingatto F. E., Santos A. C., Uyemura S. A., Jordani M. C., Curti C. In vitro interaction of nonsteroidal anti-inflammatory drugs on oxidative phosphorylation of rat kidney mitochondria: respiration and ATP synthesis. Arch Biochem Biophys. 1996 Oct 15;334(2):303–308. doi: 10.1006/abbi.1996.0459. [DOI] [PubMed] [Google Scholar]
  46. Morris A. J., Madhok R., Sturrock R. D., Capell H. A., MacKenzie J. F. Enteroscopic diagnosis of small bowel ulceration in patients receiving non-steroidal anti-inflammatory drugs. Lancet. 1991 Mar 2;337(8740):520–520. doi: 10.1016/0140-6736(91)91300-j. [DOI] [PubMed] [Google Scholar]
  47. Morris A. J., Wasson L. A., MacKenzie J. F. Small bowel enteroscopy in undiagnosed gastrointestinal blood loss. Gut. 1992 Jul;33(7):887–889. doi: 10.1136/gut.33.7.887. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Rampton D. S., McNeil N. I., Sarner M. Analgesic ingestion and other factors preceding relapse in ulcerative colitis. Gut. 1983 Mar;24(3):187–189. doi: 10.1136/gut.24.3.187. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Rampton D. S., Sladen G. E. Relapse of ulcerative proctocolitis during treatment with non-steroidal anti-inflammatory drugs. Postgrad Med J. 1981 May;57(667):297–299. doi: 10.1136/pgmj.57.667.297. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Ravi S., Keat A. C., Keat E. C. Colitis caused by non-steroidal anti-inflammatory drugs. Postgrad Med J. 1986 Aug;62(730):773–776. doi: 10.1136/pgmj.62.730.773. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Reuter B. K., Davies N. M., Wallace J. L. Nonsteroidal anti-inflammatory drug enteropathy in rats: role of permeability, bacteria, and enterohepatic circulation. Gastroenterology. 1997 Jan;112(1):109–117. doi: 10.1016/s0016-5085(97)70225-7. [DOI] [PubMed] [Google Scholar]
  52. Robert A., Asano T. Resistance of germfree rats to indomethacin-induced intestinal lesions. Prostaglandins. 1977 Aug;14(2):333–341. doi: 10.1016/0090-6980(77)90178-2. [DOI] [PubMed] [Google Scholar]
  53. Rooney P. J., Jenkins R. T., Smith K. M., Coates G. 111Indium-labelled polymorphonuclear leucocyte scans in rheumatoid arthritis--an important clinical cause of false positive results. Br J Rheumatol. 1986 May;25(2):167–170. doi: 10.1093/rheumatology/25.2.167. [DOI] [PubMed] [Google Scholar]
  54. Satoh H., Guth P. H., Grossman M. I. Role of bacteria in gastric ulceration produced by indomethacin in the rat: cytoprotective action of antibiotics. Gastroenterology. 1983 Mar;84(3):483–489. [PubMed] [Google Scholar]
  55. Schwartz H. A. Lower gastrointestinal side effects of nonsteroidal antiinflammatory drugs. J Rheumatol. 1981 Nov-Dec;8(6):952–954. [PubMed] [Google Scholar]
  56. Segal A. W., Isenberg D. A., Hajirousou V., Tolfree S., Clark J., Snaith M. L. Preliminary evidence for gut involvement in the pathogenesis of rheumatoid arthritis? Br J Rheumatol. 1986 May;25(2):162–166. doi: 10.1093/rheumatology/25.2.162. [DOI] [PubMed] [Google Scholar]
  57. Somasundaram S., Hayllar H., Rafi S., Wrigglesworth J. M., Macpherson A. J., Bjarnason I. The biochemical basis of non-steroidal anti-inflammatory drug-induced damage to the gastrointestinal tract: a review and a hypothesis. Scand J Gastroenterol. 1995 Apr;30(4):289–299. doi: 10.3109/00365529509093280. [DOI] [PubMed] [Google Scholar]
  58. Somasundaram S., Rafi S., Hayllar J., Sigthorsson G., Jacob M., Price A. B., Macpherson A., Mahmod T., Scott D., Wrigglesworth J. M. Mitochondrial damage: a possible mechanism of the "topical" phase of NSAID induced injury to the rat intestine. Gut. 1997 Sep;41(3):344–353. doi: 10.1136/gut.41.3.344. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Somasundaram S., Rafi S., Jacob M., Sigthorsson G., Mahmud T., Sherwood R., Price A. B., Macpherson A., Scott D., Wrigglesworth J. M. Intestinal tolerability of nitroxybutyl-flurbiprofen in rats. Gut. 1997 May;40(5):608–613. doi: 10.1136/gut.40.5.608. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Sukumar L. Recurrent small bowel obstruction associated with piroxicam. Br J Surg. 1987 Mar;74(3):186–186. doi: 10.1002/bjs.1800740310. [DOI] [PubMed] [Google Scholar]
  61. Tanner A. R., Raghunath A. S. Colonic inflammation and nonsteroidal anti-inflammatory drug administration. An assessment of the frequency of the problem. Digestion. 1988;41(2):116–120. doi: 10.1159/000199740. [DOI] [PubMed] [Google Scholar]
  62. Tibble J. A., Sigthorsson G., Foster R., Scott D., Fagerhol M. K., Roseth A., Bjarnason I. High prevalence of NSAID enteropathy as shown by a simple faecal test. Gut. 1999 Sep;45(3):362–366. doi: 10.1136/gut.45.3.362. [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. Wallace J. L. Non-steroidal anti-inflammatory drug gastropathy and cytoprotection: pathogenesis and mechanisms re-examined. Scand J Gastroenterol Suppl. 1992;192:3–8. doi: 10.3109/00365529209095973. [DOI] [PubMed] [Google Scholar]
  64. Wax J., Clinger W. A., Varner P., Bass P., Winder C. V. Relationship of the enterohepatic cycle to ulcerogenesis in the rat small bowel with flufenamic acid. Gastroenterology. 1970 Jun;58(6):772–780. [PubMed] [Google Scholar]
  65. Weiss S. J. Tissue destruction by neutrophils. N Engl J Med. 1989 Feb 9;320(6):365–376. doi: 10.1056/NEJM198902093200606. [DOI] [PubMed] [Google Scholar]
  66. Wilson R. G., Smith A. N., Macintyre I. M. Complications of diverticular disease and non-steroidal anti-inflammatory drugs: a prospective study. Br J Surg. 1990 Oct;77(10):1103–1104. doi: 10.1002/bjs.1800771008. [DOI] [PubMed] [Google Scholar]
  67. Yamada T., Deitch E., Specian R. D., Perry M. A., Sartor R. B., Grisham M. B. Mechanisms of acute and chronic intestinal inflammation induced by indomethacin. Inflammation. 1993 Dec;17(6):641–662. doi: 10.1007/BF00920471. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES